Effect of chamomile capsule on lipid? and hormonal?related parameters among women of reproductive age with polycystic ovary syndrome
and 24.38 ± 6.14 years in the intervention and control groups, espectively. Decreased level of testosterone was observed in the intervention group (in women with PCOS) who received chamomile capsules (P = 0.017). A signifcant di?erence was not seen in low?density lipoprotein cholesterol level (P = 0.249), high?density lipoprotein cholesterol (P = 0.073), triglycerides (P = 0.603), the hormone dehydroepiandrosterone sulfate (P = 0.423), and the ratio of luteinizing hormone/follicle?stimulating hormone (LH/FSH) in the experimental and control groups after the intervention (P = 0.420). Conclusion: According to the fndings, oral administration of chamomile capsule caused a signifcant decrease in total testosterone levels in these patients. However, no signifcant change was
reported with lipid parameters, the ratio of LH/FSH, and dehydroepiandrosterone sulfate level.
This article has been downloaded 32 times up to now.
This work is licensed under a Creative Commons Attribution 3.0 License.